About LivCorp Inc.
Headquartered in Burlington, Ontario, Canada, LivCorp Inc. is comprised of a team of innovators who bring together 125 years of medical and corporate experience. The goal of the company is to develop natural, safe and effective medications, using a revolutionary new delivery system, delivra™.
Dr. Joseph Gabriele, Ph.D.
Chief Scientific Offer
Dr. Gabriele works in the field of Psychiatry and Behavioural Neurosciences and holds a Ph.D. in Neuropharmacology. Dr. Gabriele specializes in the study of signal transduction pathways in numerous disease states.
Chris Schnarr, MBA
Mr. Schnarr has 24 years of experience founding, managing, and advising growth companies, including strategy corporate finance, capital markets, corporate development, M&A, financial reporting, and governance. His broad industry experience spans technology (hardware, software, and services), communications, agriculture, food processing and food ingredients, financial services, healthcare, and sustainability. Mr. Schnarr has 18 years public company Board experience, across TSXV and TSX listed companies, as well as extensive committee experience. He is presently a director and chair of the Audit Committee and member of the Governance and Compensation Committees of Legumex Walker Inc. (LWP‐TSX) Mr. Schnarr holds a master’s in business administration (finance) from University of British Columbia (1990), and a bachelor of business administration degree with a minor in economics, from Wilfrid Laurier University (1989). He is a member of the Institute of Corporate Directors and is presently completing the Directors. Education Program at the Rotman School of Business at the University of Toronto.
Vice President, Sales & Distribution
Mr. Ferris comes to LivCorp with 21 years of experience in the nutraceutical industry. His skill sets include specialty retail, brand consultation, and distribution.
Principal Investigator In Clinical Trials for LivRelief Products
Dr. Mary Lynch, MD, FRCPC
Dr. Mary Lynch is Professor of Anesthesia, Psychiatry and Pharmacology at Dalhousie University and Director of Research at the Pain Management Unit, QEII Health Sciences Centre. Dr. Lynch is also the immediate President of the Canadian Pain Society. She has 25 years of experience as a clinician and researcher assisting patients with chronic pain.
Board of Advisors
Mr. Richard M. Stein, B.Sc. (Pharm.), FACA
During the past 15 years, Richard has specialized as a compounding pharmacist. He has been providing customized medications to meet patients’ unique and individual needs. Richard has served two terms as Regional Director for Canada on the Board of Directors of the American College of Apothecary and more recently on the Board of Directors for the International Association of Compounding Pharmacists.
Dr. Mark Scappaticci, B.Sc. (Hons), DAt, FCCSS, CKTI
Dr. Scappaticci completed his Fellowship in Chiropractic Sport Sciences in ‘95 and has played a role in the last 3 Summer Olympics and last 2 Winter Olympics games. He consults for the Toronto Blue Jays, Toronto Maple Leafs and Chicago Black Hawks.
Dr. Jennifer M. Raoul, PhD
Dr. Raoul is a Patent Agent of Borden Ladner Gervais LLP, a leading life sciences national law firm. Jennifer has a PhD in Pharmacology from Dalhousie University. Jennifer specializes in assessment of IP, drafting and prosecution of patent applications, due diligence and opinion work, related to all areas of life sciences.
Mr. Gabriele Gaetani
Gabriele is CEO of TWS, a large multi-national shipping and logistic company for pharma giant, The Comifar Group, as well as for products such as: Dolce & Gabbana, Fendi and Moschino. Gabriele was educated at the University of Siena, Italy in economics. Mr. Gaetani’s company has grown to have over 120 employees and TWS has offices in Asia, Eastern Europe, Western Europe and North America.
Mr. Dennis Beraldo B.A. B.Ed
Dennis served as Vice President Administration, Vice President Operations and co COO of the Venetor Group, one of the largest Independent Equipment Rental companies in North America. Dennis specializes in sales, marketing and public relations.
Dr. Angelo Frisina, B.Sc, (Biochem), D.C., RCCSS (c)
Dr. Frisina is the owner and Clinic Director of the multidisciplinary rehabilitation clinic, Stoney Creek Rehab & Wellness Centre for over 23 years. He holds a Fellowship from the Royal College of Chiropractic Sport Science (Canada), is certified as a Functional Capacity Evaluator and Independent Chiropractor Evaluator for IME’s. He is also the CEO of Phases Rehab, a software company that provides a comprehensive exercise database system.
Dr. Mark A. Ferro, PhD
Dr. Ferro is an Assistant Professor of Psychiatry & Behavioural Neurosciences and Pediatrics at McMaster University. As an epidemiologist, he has expertise in the design, conduct, and analysis of research studies.
Dr. John Maletta, DDS
office 905 639 7878
cell 905 220 8539
fax 905 639 7864
1155 Appleby Line, Unit D1
Burlington, Ontario, L7L 5H9